(Q44806188)
Statements
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial (English)
L Nguyen
M Riggi
M Amiel
D Valteau-Couanet
P Brock
R Ladenstein